Chemically-Induced Disorders
Conditions
Interventions
Stage 1 - Content validation study: It will consist of a study for validation of content of 36 Short Message Service (SMS), which will be developed and later validated using the Delphi technique. The
Recruitment: Potential participants will be identified in the health units (individual analysis of medical records) and in the municipal pharmacy (benzodiazepine dispensing records). Elderly patients
Control Group: The control group will continue to receive conventional care from the health team and will receive the application of the Mini Mental State Exam (MEEM) - test used to evaluate the cogni
Intervention Group (T1 Meeting): a medical consultation will be performed at the unit for clinical evaluation and to verify the aptitude to participate in the study. After a medical consultation, they
Drug
E01.370.225.625.115.320
Sponsors
Universidade Federal de São João del-Rei
Universidade Federal de São João del-Rei
Eligibility
Inclusion criteria
Inclusion criteria: First stage: medical professionals, nurses and pharmacists with clinical and/or academic experience in the care of the elderly will be included. For analysis of the understanding of the content of the messages will be included seniors who are 60 years or older, who can read and who do not use benzodizepines; Second and third stages: Elderly will be included from all units in the urban area of the municipality in chronic use of benzodiazepines for anxiety and insomnia, administered daily for at least three months, which were attended in one of the ESF.
Exclusion criteria
Exclusion criteria: Patients who use benzodiazepines for the treatment of epilepsy, psychiatric illness with a history of psychosis and alcohol and illegal drug addicts will be excluded; patients who are not cognitively competent, according to the mini-mental state examination - MEEM-23.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Verify the desprescription of benzodiazepine by reducing the dose and removing benzodiazepines from the elderly. This will be done by applying a benzodiazepine deprescription protocol in a simple randomization programmatic clinical trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| Asses the quality of life, which will be measured before and after the intervention through the Word Health Organization Quality of Life Group WHOQOL-BREF questionnaire.;Assess health condition related to signs and symptoms of abstinence. The Benzodiazepine Abstinence Signs and Symptoms Questionnaire will be used for health evaluation.;See the perception of the elderly regarding the process of desprescription, which will be analyzed through the Focal Group technique, and the content will be transcribed in its entirety and analyzed qualitatively by the content analysis proposal according to Bardin, 2009. | — |
Countries
Brazil
Contacts
Public ContactAndré Baldoni
Universidade Federal de São João del-Rei
Outcome results
None listed